Skip to content

Therapeutic mechanism and patient acceptability of acupuncture in treating dry eye syndrome

Therapeutic mechanism and patient acceptability of acupuncture in treating dry eye syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000077
Enrollment
Unknown
Registered
2025-01-13
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dry eye disease

Interventions

Treatment group:Acupuncture: Fengchi, Tianzhu, Wangu, Taiyang, Zanzhu. 1)0.25×30mm needles. Fengchi (nose direction), others (20-25mm, straight). Twist 1 min, leave 30 min. 2)Eyes: 0.25mm×15mm needles
control group:Use sodium hyaluronate eye drops (5ml 0.1%), 0.1ml three times daily for 6 weeks. Clean eyes with a cotton swab before use. Look up, pull down the lower eyelid, drop in one drop, then co

Sponsors

Sheng Ruya
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Include patients: 1) Aged 18-80 years old; 2) The diagnostic criteria of dry eye are suitable; (3) Other intervention measures for dry eye were stopped for >1 week before enrollment; 4) if suffering from chronic diseases but does not affect dry eye disease sodium hyaluronate eye drops acupuncture treatment; 5) Patients voluntarily participated in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1) Those who do not conform to the above diagnostic and inclusion criteria; 2) Those who do not comply with the requirements of treatment; 3) Patients with blepharitis blepharitis entropion trichiasis incomplete closure of the eyelid and other eyelid diseases affecting the tear film; (4) Patients with dacryadenitis dacryocystitis conjunctivitis conjunctivitis keratitis pterygium glaucoma iritis and other anterior segment active diseases affecting tear film; 5) Patients with severe life-threatening conditions such as circulation nervous system and blood system; (6) Diabetes mental diseases such as the need for continuous medication can cause tear reduction; 7) Patients who cannot receive floating needle reperfusion or sodium hyaluronate eye drops for other reasons.

Design outcomes

Primary

MeasureTime frame
Tearmeniscus height;Schirmer I test;Break up time;

Secondary

MeasureTime frame
Integral evaluation of TCM syndrome;Ocular Surface Disease Index;

Countries

China

Contacts

Public ContactSheng Ruya

Changzhou Third People's Hospital

404582868@qq.com13337899759

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026